Canadian Cancer Trials Group Bulletins

Audit Monitoring Group

Consent Form Review Policy

Effective 27 September 2010, Canadian Cancer Trials Group will be reviewing local consent forms to ensure that they are in compliance with Canadian Cancer Trials Group SOPs only, particularly regarding compensation, drug supply and access to participant/potential participant records. It is the shared responsibility of the local REB and Principal Investigator to ensure that local consent form(s) are accurate and compliant with GCP and all applicable regulatory requirements, particularly with respect to any changes that have been made (compared to the trial sample consent).

Please see the memo posted at

Further information on Canadian Cancer Trials Group's consent form policy can be found on the (newly updated) Canadian Cancer Trials Group website at

For questions, please contact Erin Bell, Ethics Team Leader, at or 613-533-6430.